Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
Completed
Eli Lilly and Company
Phase 3
2007-06-01
The purpose of this study is to examine the efficacy and safety of insulin lispro protamine
suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime
insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for
sequentially testing the secondary objectives.
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
Completed
Eli Lilly and Company
Phase 3
2007-08-01
The purpose of this study is to examine the effectiveness and safety of insulin lispro
protamine suspension (ILPS) as compared to insulin detemir as basal insulin therapy in adults
with type 2 diabetes. A gatekeeper strategy will be employed for sequentially testing the
secondary objectives.
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)
Completed
Eli Lilly and Company
Phase 3
2007-08-01
The purpose of this study is to examine the effectiveness and safety of insulin lispro
protamine suspension (ILPS) as compared to insulin glargine as basal insulin therapy in
adults with type 2 diabetes.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
